Granulosa cell tumour: Review of the literatu;Tumeur a cellules de la granulosa: Revue de la litterature

Bulletin du Cancer

Volumn 87, Issue 10, 2000, Pages 709-714

  Bompas, E ^a   Freyer, G ^a   Vitrey, D ^a   Trillet Lenoir, V ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Chemotherapy; Granulosa cell tumour; Surgery

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; TUMOR PROTEIN;

CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CELL STRUCTURE; CLINICAL FEATURE; ENDOMETRIUM HYPERPLASIA; GRANULOSA CELL TUMOR; HISTOPATHOLOGY; HUMAN; ONSET AGE; OVARY CARCINOMA; PATHOLOGICAL ANATOMY; PROGNOSIS; PUBERTY; REVIEW; AGE; FEMALE; METABOLISM; MULTIMODALITY CANCER THERAPY; OVARY TUMOR; PATHOLOGY;

AGE FACTORS; COMBINED MODALITY THERAPY; FEMALE; GRANULOSA CELL TUMOR; HUMANS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PROGNOSIS;

EID: 0034294590     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Clinical review of adult granulosa cell tumors of the ovary
2. Clinicopathologic review of 118 granulosa and 82 theca cell tumors
3. Prognostic factors in granulosa-cell tumors
4. Granulosa cell tumors of the ovary: Clinicopathological study of 118 cases with long-term follow-up
5. Flow cytometric ploidy analysis of ovarian granulosa cell tumors
6. Juvenile granulosa cell tumors of the ovary
7. Granulosa theca cell tumors in premenarchal girls: A clinical and pathologic study of ten cases
8. Juvenile granulosa cell tumor
9. Juvenile granulosa cell tumor
10. Observations on chemotherapy of granulosa cell carcinomas and malignant ovarian teratomas
11. Inhibin as a marker for ovarian cancer
12. Immunohistochemical staining of ovarian granulosa cell tumors with monoclonal antibody against inhibin
13. Value of inhibin in the identification of granulosa cell tumors of the ovary
14. Production of antimullerian hormone: Another homology between sertoli and granulosa cells
15. Mullerian inhibiting substance as a marker for ovarian sex-cord tumor
16. Antimullerian hormone as a serum marker of granulosa cell tumors of the ovary: Comparative study with serum alpha-inhibin and estradiol
17. Granulosa cell tumors: Clinical review of 61 cases
18. Granulosa cell tumors in Israel: A study of 172 cases
19. Treatment of ovarian stromal tumors
20. Adult granulosa-cell tumor of the ovary: A retrospective study of 45 cases
21. Juvenile granulosa cell tumor of the ovary in children: A clinical study of 15 cases
22. Granulosa tumors of the ovary in children: A clinical and pathologic study of 32 cases
23. Granulosa cell tumors of the ovary in children and adolescents. Multicenter retrospective study in 40 patients aged 7 months to 22 years
24. Juvenile granulosa cell tumors of the ovary in children and adolescents: Results from 33 patients registered in a prospective cooperative study
25. Sex cord-stromal tumours of the ovary
26. Prognostic factors in adult granulosa cell tumor of the ovary
27. Juvenile granulosa cell tumor of the ovary. Clinicopathological analysis of 125 cases
28. Granulosa cell tumors of the ovary: Prognostic factors and outcome
29. Mitotic count, nuclear atypia, and immunohistochemical determination of ki-67, c-myc, p21-ras, c-erbb2, and p53 expression in granulosa cell tumors of the ovary: Mitotic count and ki-67 are indicators of poor prognosis
30. Ploidy of ovarian granulosa cell tumors: Lack of correlation between index or proliferative index and outcome in 40 patients
31. Flow cytometric analysis of granulosa tumors
32. Combined analysis of flow cytometry and morphometry of ovarian granulosa cell tumor
33. Granulosa cell tumor of the ovary. Histopathologic and flow cytometric analysis with clinical correlation
34. Prognostic value of flow cytometric content analysis in granulosa cell tumor of the ovary
35. Transformation in recurrent ovarian granulosa cell tumors: Ki67 -1 and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior
36. Prognostic significance of p53 expression in ovarian granulosa cell tumors
37. Over-expression of p53 is not a feature of ovarian granulosa cell tumors
38. Inhibin as a market for granulosa-cell tumors
39. Monoclonal antibodies against inhibin represent key markers of adult granulosa cell tumors of the ovary even in their metastases. Report of three cases with late metastasis, being previously misinterpreted as hemangiopeticytoma
40. Serum inhibin and disease status in women with ovarian granulosa cell tumors
41. Prospective study of inhibin in granulosa cell tumors of the ovary
42. Diagnostic utility of mulletian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors
43. Cisplatin, vinblastine, and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary
44. Cisplatin-containing regimen in advanced ot recurrent granulosa cell tumours of the ovary
45. Cis-platinum/vinblastine/bleomycin combination chemotherapy in advanced or recurrent granulosa cell tumors of the ovary
46. Combination chemotherapy of ovarian granulosa cell tumor with cis-platinum and doxorubicin
47. Cyclophosphamide, adriamycin, and cis-platinum for the treatment of advanced granulosa cell tumor, using serum estradiol as a tumor marker
48. Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide
49. Temporary response of recurrent granulosa cell tumor to adriamycin
50. Adriamycin and bleomycin, alone and in combination, in gynecologic cancers
51. Chemotherapy of granulosa cell tumors
52. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin
53. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A gynecologic oncology group study
54. Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary
55. Megestrol activity in recurrent adult type granulosa cell tumour of the ovary
56. Gonadotropin-releasing hormone agonist analog therapy effective in ovarian granulosa cell malignancy
57. Expression and regulation of gonadotropin-releasing hormone (gnrh) and gnrh receptor messenger ribonucleic acids in human granulosa-luteal cells
58. Cisplatin (p), vinblastine (v) and bleomycin (b) combination chemotherapy in recurrent or advanced granulosa cell tumor of the ovary (gcto): An EORTC Gynecol. Cancer Coop. Group Study